Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Nanoform Finland Plc an innovative nanoparticle medicine enabling company and Nacuity Pharmaceuticals a Texasbased clinical stage pharmaceutical company today announced that they have signed a Technology Proof of Concept PoC Agreement with compensati...
The European Commission EC has approved mAbxiences MB biosimilar to Avastin Bevacizumab in EuropeMB to be commercialized as Alymsys and Oyavas is highly similar to the reference medicinal product and data has shown a comparable quality safety and eff...
Charles River Laboratories International Inc announced today that it hasacquired Retrogenix Limited an earlystage contract research organization CRO providing specialized bioanalytical services utilizing its proprietarycell microarray technology
Zai Lab an innovative commercialstage biopharmaceutical company and Deciphera Pharmaceuticals NASDAQ DCPH a commercialstage biopharmaceutical company developing innovative medicines to improve the lives of people with cancer
The US Food and Drug Administration FDA has approved Sarclisa isatuximabirfc in combination with carfilzomib and dexamethasone Kd for the treatment of adult patients with relapsed or refractory multiple myeloma RRMM who have received one to three pri...
Amgen Inc and Rodeo Therapeutics Corporation Rodeo today announced an agreement under which Amgen will acquire Rodeo a privately held biopharmaceutical company based in Seattle that develops smallmolecule therapies designed to promote regeneration an...
AbbVie today announced that the US Food and Drug Administration FDA has accepted its New Drug Application NDA for atogepant an investigational orally administered calcitonin generelated peptide CGRP receptor antagonist gepant for the preventive treat...
Novartis announced today that the European Commission has approved Kesimpta ofatumumab for the treatment of relapsing forms of multiple sclerosis RMS in adults with active disease defined by clinical or imaging features Kesimpta is a targeted
Merck known as MSD outside the United States and Canada today announced that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has adopted a positive opinion recommending that the European label for KEYTRUDA
Roche today announced that the European Commission EC has approved Evrysdi risdiplam for the treatment of q spinal muscular atrophy SMA in patients two months of age and older with a clinical diagnosis of SMA Type Type or Type or with one to four...
